# Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization

> **NCT03142412** · — · UNKNOWN · sponsor: **DxTerity Diagnostics** · enrollment: 2500 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Lupus
- Lupus Erythematosus
- Lupus Erythematosus, Systemic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03142412
- **Lead sponsor:** DxTerity Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-17
- **Primary completion:** 2021-10-17
- **Final completion:** 2021-10-17
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03142412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03142412, "Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03142412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*